Answers are grounded in this paper and cite their sources.
Demonstrates selective binding of methotrexate in vitro, indicating potential for antidote development.
We describe the preparation, assembly, recognition characteristics, and bioactivity of dendritic basket 6 12− . This novel cavitand has a deep aromatic pocket with three ( S )‐glutamic acid dendrons at the rim to amplify water solubility and prevent self‐association. 1 H NMR spectroscopy, calorimetry (ITC), and mass spectrometry (ESI‐MS) measurements validate the formation of an inclusion complex between 6 12− and anticancer drug methotrexate (MTX 2− ) in water ( K d =9.2 μM). To identify the docking pose, a comparison of computed (DFT and MM) and experimental 1 H NMR chemical shifts suggests that MTX 2− folds inside 6 12− (π⋅⋅⋅π), forming HBs with the peptidic dendrons while anchoring (C−H⋅⋅⋅π) to the aromatic pocket through its N‐methyl group. In consequence, 6 12− selectively binds MTX 2− in competition with structurally similar folic acid and leucovorin (reversal poisoning agent). While the host is biocompatible (HEK293; IC 50 >150 μM) and produces inclusion complex [MTX⊂ 6 ] 14− in cell media, it experiences limitation in pharmacokinetic sequestration of MTX 2− as dihydrofolate reductase's affinity to the drug is suggested to prevail over that of 6 12− . Nonetheless, considering the basket's biocompatibility, tunability, and chemoselectivity, it stands as the leading candidate in the pursuit of an effective abiotic antidote for methotrexate poisoning.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: